No Detail Found!

Treatment of vertigo- with & without anxiolytic drug (alprazolam 0.25mg)

Author(s)
Muhammad Waqas Ayub Combined Military Hospital Okara/National University of Medical Sciences (NUMS), Pakistan
Syed Muhammad Asad Shabbir Bukhari Pakistan Naval Ship Shifa, Karachi, Pakistan
Mohsin Raza Combined Military Hospital Okara/National University of Medical Sciences (NUMS), Pakistan
Asma Waqas Fazal Din Trust Hospital, Okara, Pakistan.
Beenish Hassan Khan Combined Military Hospital Okara/National University of Medical Sciences (NUMS), Pakistan
Atif Najam Pakistan Naval Ship Hafeez, Islamabad, Pakistan
Abstract
Objective: To compare the effect of using the tablet Alprazolam 0.25mg in the treatment outcome of vertigo related anxiety by beck anxiety inventory. Study Design: Comparative study. Place and Duration of Study: Combined Military Hospital Okara Cantt, Sep 2018 to Jun 2020. Methodology: A total of 384 patients were included in the study. They were randomly assigned to group A and B by randomized clinical trial. Group A was given tablet alprazolam 0.25 mg along with the conventional treatment of vertigo and group B was given the treatment of vertigo only and no anxiolytic was added. Their pre & post treatment (after 2 weeks) anxiety level using Beck anxiety inventory was scored. Results: There was a significant improvement in group A patient's vertigo effects after treatment with alprazolam. Also, it was observed that group A patients responded significant improvement in anxiety score as compared to Group B patients 02 weeks post treatment. Conclusion: Antianxiety treatment should be added in all cases with the conventional treatment of vertigo to reduce the vertigo associated anxiety of the patients.
Publication Details
Page(s) 445-447
Published Journal: Pakistan Armed Forces Medical Journal, Volume: 71, Issue: S3, Year: 2021

Request the full text from PASTIC

Keywords
Anxiety, Vertigo, Tablet alprazolam.
0

Citations

0

Downloads

68

Views